Clinical Trial

Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT)

Study acronym: INDICT
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study is a randomized Phase 2 trial to determine the feasibility of real-time electrocorticographic monitoring of spreading depolarizations (SD) to guide implementation of a tier-based protocol of intensive care therapies, aimed at SD suppression, for the management of patients who have undergone acute operative treatment of severe traumatic brain injury.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-04-14; most recent amendment 2025-12-16.
Status change: Not Yet Recruiting → Recruiting 2023-09-11
Trial Details
NCT Number NCT05337618
Lead Sponsor University of Cincinnati
Collaborators: University of New Mexico, University of Pennsylvania
Conditions Traumatic Brain Injury
Enrollment 72 participants
Start Date 2022-12-16
Primary Completion 2026-09-01 (estimated)
Study Completion 2027-03-20 (estimated)
Updated on ClinicalTrials.gov 2025-12-22